Results
|
21.
|
|
|
22.
|
|
|
23.
|
|
|
24.
|
|
|
25.
|
|
|
26.
|
|
|
27.
|
|
|
28.
|
|
|
29.
|
|
|
30.
|
Platelet glycoprotein IIb/IIIa receptor blockers: An appropriate-use model for expediting care in acute coronary syndromes. [electronic resource] by
- Kereiakes, D J
- McDonald, M
- Broderick, T
- Roth, E M
- Whang, D D
- Martin, L H
- Howard, W L
- Schneider, J
- Shimshak, T
- Abbottsmith, C W
Producer: 20000303
In:
American heart journal vol. 139
Availability: No items available.
|
|
31.
|
High platelet count in platelet-rich plasma reduces measured platelet inhibition by abciximab but not tirofiban nor eptifibatide glycoprotein IIb/IIIa receptor antagonists. [electronic resource] by
- Kereiakes, D J
- Broderick, T M
- Roth, E M
- Whang, D
- Mueller, M
- Lacock, P
- Anderson, L C
- Howard, W
- Blanck, C
- Schneider, J
- Abbottsmith, C A
Producer: 20000310
In:
Journal of thrombosis and thrombolysis vol. 9
Availability: No items available.
|
|
32.
|
Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention. [electronic resource] by
- Kereiakes, D J
- Broderick, T M
- Roth, E M
- Whang, D
- Shimshak, T
- Runyon, J P
- Hattemer, C
- Schneider, J
- Lacock, P
- Mueller, M
- Abbottsmith, C W
Producer: 19990915
In:
The American journal of cardiology vol. 84
Availability: No items available.
|
|
33.
|
Coronary stent placement in patients with acute myocardial infarction: comparison of clinical and angiographic outcome after randomization to antiplatelet or anticoagulant therapy. [electronic resource] by
- Schömig, A
- Neumann, F J
- Walter, H
- Schühlen, H
- Hadamitzky, M
- Zitzmann-Roth, E M
- Dirschinger, J
- Hausleiter, J
- Blasini, R
- Schmitt, C
- Alt, E
- Kastrati, A
Producer: 19970211
In:
Journal of the American College of Cardiology vol. 29
Availability: No items available.
|
|
34.
|
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. [electronic resource] by
- Schömig, A
- Neumann, F J
- Kastrati, A
- Schühlen, H
- Blasini, R
- Hadamitzky, M
- Walter, H
- Zitzmann-Roth, E M
- Richardt, G
- Alt, E
- Schmitt, C
- Ulm, K
Producer: 19960425
In:
The New England journal of medicine vol. 334
Availability: No items available.
|
|
35.
|
Combination enoxaparin-abciximab therapy during coronary intervention: the next standard of care? [electronic resource] by
- Tramuta, D A
- Kereiakes, D J
- Dippel, E J
- Lengerich, R
- Broderick, T M
- Abbottsmith, C W
- Whang, D D
- Roth, E M
- Schneider, J F
- Howard, W
- Shimshak, T M
Producer: 20050420
In:
The Journal of invasive cardiology vol. 12 Suppl C
Availability: No items available.
|
|
36.
|
Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: an algorithm for percutaneous management. [electronic resource] by
- Dippel, E J
- Kereiakes, D J
- Tramuta, D A
- Broderick, T M
- Shimshak, T M
- Roth, E M
- Hattemer, C R
- Runyon, J P
- Whang, D D
- Schneider, J F
- Abbottsmith, C W
Producer: 20010628
In:
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions vol. 52
Availability: No items available.
|
|
37.
|
Abciximab provides cost-effective survival advantage in high-volume interventional practice. [electronic resource] by
- Kereiakes, D J
- Obenchain, R L
- Barber, B L
- Smith, A
- McDonald, M
- Broderick, T M
- Runyon, J P
- Shimshak, T M
- Schneider, J F
- Hattemer, C R
- Roth, E M
- Whang, D D
- Cocks, D
- Abbottsmith, C W
Producer: 20001102
In:
American heart journal vol. 140
Availability: No items available.
|